Ivan Semenyuta

444 total citations
37 papers, 328 citations indexed

About

Ivan Semenyuta is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Ivan Semenyuta has authored 37 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Organic Chemistry, 12 papers in Molecular Biology and 12 papers in Computational Theory and Mathematics. Recurrent topics in Ivan Semenyuta's work include Synthesis and biological activity (20 papers), Computational Drug Discovery Methods (12 papers) and Ionic liquids properties and applications (8 papers). Ivan Semenyuta is often cited by papers focused on Synthesis and biological activity (20 papers), Computational Drug Discovery Methods (12 papers) and Ionic liquids properties and applications (8 papers). Ivan Semenyuta collaborates with scholars based in Ukraine, Germany and United States. Ivan Semenyuta's co-authors include Larysa Metelytsia, Vasyl Kovalishyn, Diana Hodyna, В. С. Броварец, Sergiy Rogalsky, Vsevolod Yu. Tanchuk, Oksana Tarasyuk, Igor V. Tetko, Olena Moshynets and Pavel Karpov and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Environmental Science and Pollution Research.

In The Last Decade

Ivan Semenyuta

32 papers receiving 320 citations

Peers

Countries citing papers authored by Ivan Semenyuta

Since Specialization

Citations

This map shows the geographic impact of Ivan Semenyuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Semenyuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Semenyuta more than expected).

Fields of papers citing papers by Ivan Semenyuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Semenyuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Semenyuta. The network helps show where Ivan Semenyuta may publish in the future.

Co-authorship network of co-authors of Ivan Semenyuta

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Semenyuta. A scholar is included among the top collaborators of Ivan Semenyuta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Semenyuta. Ivan Semenyuta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New QSTR models to evaluation of imidazolium- and pyridinium-contained ionic liquids toxicity 2024 ·Computational Toxicology ·Ivan Semenyuta, Vasyl Kovalishyn, Diana Hodyna, (unknown), Sergiy Rogalsky, Larysa Metelytsia	6
2	In silico modeling and experimental validation of 2-oxoimidazolidin-4-sulfonamides as low-toxicity fungicides against Phytophthora infestans 2024 ·SHILAP Revista de lepidopterología ·Vasyl Kovalishyn, Diana Hodyna, Ivan Semenyuta, В. С. Броварец, Oleh Shablykin, (unknown), Larysa Metelytsia	0
3	Design, synthesis and anticancer activity of novel 4-(5-amino-4-cyano-1,3-oxazol-2-yl)benzenesulfonamide derivative 2024 ·Current Chemistry Letters ·(unknown), (unknown), Ivan Semenyuta, (unknown), (unknown), (unknown)	1
4	Anticancer activity features of imidazole-based ionic liquids and lysosomotropic detergents: in silico and in vitro studies 2024 ·Molecular Diversity ·(unknown), Petro Borysko, (unknown), (unknown), Diana Hodyna, Ivan Semenyuta, Vasyl Kovalishyn, Larysa Metelytsia, Sergiy Rogalsky, Sergey Tcherniuk	3
5	Synthesis, Characterization, In Vitro Anticancer Evaluation, ADMET Properties, and Molecular Docking of Novel 5‐Sulfanyl Substituted (Thiazol‐4‐yl)‐Phosphonium Salts 2024 ·ChemMedChem ·Ivan Semenyuta, (unknown), (unknown), (unknown), (unknown), В. С. Броварец	3
6	Undecylenic acid and N,N-dibutylundecenamide as effective antibacterials against antibiotic-resistant strains 2023 ·SHILAP Revista de lepidopterología ·(unknown), Diana Hodyna, Ivan Semenyuta, Oksana Tarasyuk, Sergiy Rogalsky, Larysa Metelytsia	1
7	Synthesis, Characterization and in vitro Anticancer Evaluation of 5‐Sulfinyl(sulfonyl)‐4‐arylsulfonyl‐Substituted 1,3‐Oxazoles 2023 ·ChemMedChem ·(unknown), (unknown), (unknown), (unknown), Ivan Semenyuta, (unknown), (unknown), В. С. Броварец	5
8	Antibacterial Activity of 1-Dodecylpyridinium Tetrafluoroborate and Its Inclusion Complex With Sulfobutyl Ether-β-Cyclodextrin Against MDR Acinetobacter baumannii Strains 2023 ·SHILAP Revista de lepidopterología ·Sergiy Rogalsky, Diana Hodyna, Ivan Semenyuta, M. S. Frasinyuk, Oksana Tarasyuk, S.V. Riabov, (unknown), Igor V. Tetko, Larysa Metelytsia	1
9	eDNA Inactivation and Biofilm Inhibition by the PolymericBiocide Polyhexamethylene Guanidine Hydrochloride (PHMG-Cl) 2022 ·International Journal of Molecular Sciences ·Olena Moshynets, (unknown), (unknown), (unknown), Larysa Metelytsia, (unknown), (unknown), Geert Potters, (unknown), (unknown), Ivan Semenyuta, Andrew J. Spiers, Oksana Tarasyuk, Sergiy Rogalsky	22
10	Decamethoxin virucidal activity: in vitro and in silico studies 2022 ·The Ukrainian Biochemical Journal ·Ivan Semenyuta, (unknown), (unknown), (unknown), (unknown), (unknown), Diana Hodyna, (unknown), (unknown), Larysa Metelytsia	0
11	Ester-Functionalized Imidazolium- and Pyridinium-Based Ionic Liquids: Design, Synthesis and Cytotoxicity Evaluation 2021 ·Biointerface Research in Applied Chemistry ·Diana Hodyna, Vasyl Kovalishyn, Ivan Semenyuta, Sergiy Rogalsky, (unknown), (unknown), Larysa Metelytsia, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	4
12	Structure-Activity Relationship Modeling and Experimental Validation of the Imidazolium and Pyridinium Based Ionic Liquids as Potential Antibacterials of MDR Acinetobacter baumannii and Staphylococcus aureus 2021 ·International Journal of Molecular Sciences ·Ivan Semenyuta, (unknown), Vasyl Kovalishyn, Sergiy Rogalsky, Diana Hodyna, Pavel Karpov, (unknown), Igor V. Tetko, Larysa Metelytsia	14
13	Design of (quinolin-4-ylthio)carboxylic acids as new Escherichia coli DNA gyrase B inhibitors: machine learning studies, molecular docking, synthesis and biological testing 2020 ·Computational Biology and Chemistry ·Larysa Metelytsia, Diana Hodyna, (unknown), Ivan Semenyuta, (unknown), (unknown), Vasyl Kovalishyn, (unknown)	17
14	1,3-Oxazole derivatives of cytisine as potential inhibitors of glutathione reductase of Candida spp.: QSAR modeling, docking analysis and experimental study of new anti-Candida agents 2020 ·Computational Biology and Chemistry ·Larysa Metelytsia, (unknown), Vasyl Kovalishyn, Diana Hodyna, (unknown), В. С. Броварец, (unknown), (unknown), (unknown), (unknown), Ivan Semenyuta	9
15	Ionic Liquids with Anti-Candida and Anticancer Dual Activity as Potential N-Myristoyltransferase Inhibitors 2019 ·Current Bioactive Compounds ·Larysa Metelytsia, (unknown), Ivan Semenyuta, Sergiy Rogalsky, (unknown), (unknown), (unknown), Diana Hodyna	1
16	In silico study of 4-phosphorylated derivatives of 1,3-oxazole as inhibitors of Candida albicans fructose-1,6-bisphosphate aldolase II 2019 ·Heliyon ·Ivan Semenyuta, (unknown), Diana Hodyna, В. С. Броварец, Larysa Metelytsia	7
17	New anti-candida active nitrogen-containing bisphosphonates as inhibitors of farnesyl pyrophosphate synthase Candida albicans 2019 ·SHILAP Revista de lepidopterología ·Larysa Metelytsia, Diana Hodyna, (unknown), Vasyl Kovalishyn, Ivan Semenyuta	4
18	Imidazolium ionic liquids as effective antiseptics and disinfectants against drug resistant S. aureus: In silico and in vitro studies 2018 ·Computational Biology and Chemistry ·Diana Hodyna, Vasyl Kovalishyn, Ivan Semenyuta, (unknown), Sergiy Rogalsky, Larysa Metelytsia	23
19	Reduced ecotoxicity and improved biodegradability of cationic biocides based on ester-functionalized pyridinium ionic liquids 2018 ·Environmental Science and Pollution Research ·(unknown), Larysa Metelytsia, Ivan Semenyuta, (unknown), (unknown), (unknown), Oksana Tarasyuk, (unknown), (unknown), Sergiy Rogalsky	24
20	Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents 2018 ·Computational Biology and Chemistry ·(unknown), Diana Hodyna, Ivan Semenyuta, (unknown), (unknown), Vasyl Kovalishyn, Larysa Metelytsia, В. С. Броварец	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact